Skip to main content
. 2022 Oct 31;79(12):1232–1241. doi: 10.1001/jamaneurol.2022.3718

Figure 2. Mean Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III Score by Allocated Group.

Figure 2.

MDS-UPDRS part III score while not taking medication and mean of the change in MDS-UPDRS part III score from baseline to follow-up time point, including participants who progressed to the high dose at 1 month who had valid outcome data at each time point.